Anagrelide
- Product NDC
- 62135-312
- 11-digit product format
- 621350312
- Labeler code
- 62135
- Product ID
- 62135-312_13156e50-28d1-0994-e063-6394a90a16ec
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Anagrelide
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Chartwell RX, LLC
- Application
- ANDA076683
- Marketing category
- ANDA
- Marketing start
- 2005-04-18
- Substance
- ANAGRELIDE HYDROCHLORIDE ANHYDROUS
- Active strength
- .5 mg/1
- Pharmacologic classes
- Decreased Platelet Production [PE], Phosphodiesterase 3 Inhibitors [MoA], Platelet-reducing Agent [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Related UNII Ingredients
| UNII | Preferred term | Registry number | Matched term |
|---|
| K9X45X0051 | ANAGRELIDE | 68475-42-3 | Anagrelide |
Packages
| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 62135-312-12 | 62135031212 | 120 CAPSULE in 1 BOTTLE (62135-312-12) | 120 capsule | 2024-02-05 | No | No | Historical |
Related DailyMed Labels
| Title | Manufacturer | Effective date | Type | Version |
|---|
| Anagrelide | Chartwell RX, LLC | 2024-03-07 | HUMAN PRESCRIPTION DRUG LABEL | 1 |